Free Trial

Korro Bio 11/12/2024 Earnings Report

Korro Bio logo
$43.67 +0.55 (+1.28%)
(As of 12/20/2024 05:16 PM ET)

Korro Bio EPS Results

Actual EPS
-$2.26
Consensus EPS
-$2.55
Beat/Miss
Beat by +$0.29
One Year Ago EPS
N/A

Korro Bio Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Korro Bio Announcement Details

Quarter
Time
After Market Closes

Conference Call Resources

Did You See Trump’s Bombshell Exec. Order 001? (Ad)

Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...

I put all the details together for you here — but please hurry. 

Korro Bio Earnings Headlines

Brokerages Set Korro Bio, Inc. (NASDAQ:KRRO) PT at $142.17
Media Humiliated: Demo of Elon’s Tech Proves They’re Wrong
Elon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.
Korro to Participate in Upcoming Investor Conferences
See More Korro Bio Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Korro Bio? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Korro Bio and other key companies, straight to your email.

About Korro Bio

Korro Bio (NASDAQ:KRRO), a biopharmaceutical company, engages in the discovery, development, and commercialization of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases primarily in the United States. Its lead product candidate is KRRO-110 which is in preclinical trials for the treatment of Alpha-1 Antitrypsin Deficiency (AATD). It uses its RNA editing platform, OPERA to generate differentiated RNA editing product candidates. The company is also developing programs for Parkinson's disease, Amyotrophic lateral sclerosis, severe alcohol-associated hepatitis, and other subsets of pain. Korro Bio, Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

View Korro Bio Profile

More Earnings Resources from MarketBeat

Upcoming Earnings